1. Home
  2. IDCC vs CYTK Comparison

IDCC vs CYTK Comparison

Compare IDCC & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IDCC
  • CYTK
  • Stock Information
  • Founded
  • IDCC 1972
  • CYTK 1997
  • Country
  • IDCC United States
  • CYTK United States
  • Employees
  • IDCC N/A
  • CYTK N/A
  • Industry
  • IDCC Multi-Sector Companies
  • CYTK Biotechnology: Pharmaceutical Preparations
  • Sector
  • IDCC Miscellaneous
  • CYTK Health Care
  • Exchange
  • IDCC Nasdaq
  • CYTK Nasdaq
  • Market Cap
  • IDCC 5.6B
  • CYTK 5.6B
  • IPO Year
  • IDCC N/A
  • CYTK 2004
  • Fundamental
  • Price
  • IDCC $215.91
  • CYTK $30.91
  • Analyst Decision
  • IDCC Strong Buy
  • CYTK Buy
  • Analyst Count
  • IDCC 1
  • CYTK 15
  • Target Price
  • IDCC $160.00
  • CYTK $73.71
  • AVG Volume (30 Days)
  • IDCC 277.7K
  • CYTK 2.4M
  • Earning Date
  • IDCC 05-01-2025
  • CYTK 05-06-2025
  • Dividend Yield
  • IDCC 0.87%
  • CYTK N/A
  • EPS Growth
  • IDCC 84.98
  • CYTK N/A
  • EPS
  • IDCC 12.66
  • CYTK N/A
  • Revenue
  • IDCC $815,481,000.00
  • CYTK $19,218,000.00
  • Revenue This Year
  • IDCC N/A
  • CYTK $24.01
  • Revenue Next Year
  • IDCC N/A
  • CYTK $698.33
  • P/E Ratio
  • IDCC $17.16
  • CYTK N/A
  • Revenue Growth
  • IDCC 33.52
  • CYTK 412.21
  • 52 Week Low
  • IDCC $111.85
  • CYTK $29.31
  • 52 Week High
  • IDCC $231.97
  • CYTK $61.38
  • Technical
  • Relative Strength Index (RSI)
  • IDCC 55.46
  • CYTK 42.13
  • Support Level
  • IDCC $210.88
  • CYTK $30.02
  • Resistance Level
  • IDCC $217.91
  • CYTK $31.27
  • Average True Range (ATR)
  • IDCC 5.03
  • CYTK 1.36
  • MACD
  • IDCC -0.39
  • CYTK 0.32
  • Stochastic Oscillator
  • IDCC 48.48
  • CYTK 61.93

About IDCC InterDigital Inc.

InterDigital Inc is a research and development company focused on wireless, video, Artificial Intelligence, and related technologies. It designs and develops technologies that enable connected, immersive experiences in a broad range of communications and entertainment products and services. The majority of revenue is generated from fixed-fee patent license agreements, with a smaller portion coming from variable royalty agreements. Geographically it operates in the United States, China, South Korea, Japan, Taiwan, and Europe, out of which the majority is from China.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: